Comparative pathogenicity of vaccinia virus and mpox virus infections in CAST/EiJ mice: Exploring splenomegaly and transcriptomic profiles

Abstract

Background: Vaccinia virus (VACV) and mpox virus (MPXV) belong to the orthopoxvirus genus and share high genetic similarity, making VACV widely used in the mpox pandemic. CAST/EiJ mice have been widely used for studying orthopoxvirus infection. However, the histopathological features of CAST/EiJ mice with mpox virus (MPXV) and vaccinia virus (VACV) infections have not been fully elucidated.

Methods: Four group of CAST/EiJ mice were challenged with low-dose VACV (10³ PFU, VACV-L), high-dose VACV (10⁶ PFU, VACV-H), MPXV (10⁶ PFU) or PBS via intraperitoneal route, and the disease signs and body weight were monitored daily. Subsequently, viral loads and titers in the blood and spleen of CAST/EiJ mice were analyzed via qPCR and TCID₅₀ assay. Finally, the spleen samples were analyzed for histopathological, immunohistochemical and RNA-seq.

Results: Herein, we found that VACV-L and MPXV caused splenomegaly via the intraperitoneal route, whereas VACV-H caused rapid lethality with limited splenomegaly. Transcriptome analysis from spleen revealed significant differences in gene expression between VACV-L and VACV-H groups, but the differentially expressed genes induced by splenomegaly between VACV-L and MPXV groups were highly similar. Furthermore, pathway enrichment analysis demonstrated that the VACV-L, VACV-H, and MPXV groups were all associated with the calcium, MAPK, and PI3K-Akt signaling pathway. Compared to the lethal infection observed in VACV-H group, the splenomegaly in the VACV-L and MPXV groups was characterized by extramedullary hematopoiesis and increased macrophages infiltration in the red pulp. Transcriptome analysis of the spleen demonstrated that the Wnt, tumor necrosis factor (TNF), and transforming growth factor β (TGF-β) signaling pathways may promote splenomegaly by modulating granulocyte infiltration and inflammatory responses. Compared to VACV-L group, the limited splenomegaly but lethality in VACV-H-infected mice might be associated with extensive splenic necrosis, diffuse congestion, and hemorrhage in the red pulp, as well as changes in the cGMP-PKG, Ras signaling, and Fc gamma R-mediated phagocytosis pathways.

Conclusions: Our findings systematically compared the pathogenicity of VACV and MPXV in CAST/EiJ mice, incorporating splenic transcriptome analysis to provide insights into the potential molecular mechanism behind orthopoxvirus-induced splenomegaly in CAST/EiJ mice.

Keywords

CAST/EiJ mice / mpox virus / signaling pathway / splenomegaly / vaccinia virus

References

[1] McCollum AM, Damon IK. Human monkeypox. Clin Infect Dis. 2014; 58(2): 260-267.

[2] Martín-Delgado MC, Martín Sánchez FJ, Martínez-Sellés M, et al. Monkeypox in humans: a new outbreak. Rev Esp Quimioter. 2022; 35(6): 509-518.

[3] WHO. WHO Director-General Declares the Ongoing Monkeypox Outbreak a Public Health Emergency of International Concern. https://www.who.int/europe/news/item/23-07-2022-who-director-general-declares-the-ongoing-monkeypox-outbreak-a-public-health-event-of-international-concern

[4] WHO. WHO Director-General Declares Mpox Outbreak a Public Health Emergency of International Concern. https://www.who.int/europe/news/item/16-08-2024-who-director-general-declares-mpox-outbreak-a-public-health-emergency-of-international-concern.

[5] Hughes AL, Irausquin S, Friedman R. The evolutionary biology of poxviruses. Infect Genet Evol. 2010; 10(1): 50-59.

[6] Ichihashi Y, Oie M. Epitope mosaic on the surface proteins of orthopoxviruses. Virology. 1988; 163(1): 133-144.

[7] Stanford MM, McFadden G, Karupiah G, Chaudhri G. Immunopathogenesis of poxvirus infections: forecasting the impending storm. Immunol Cell Biol. 2007; 85(2): 93-102.

[8] Zaitseva M, Thomas A, Meseda CA, et al. Development of an animal model of progressive vaccinia in nu/nu mice and the use of bioluminescence imaging for assessment of the efficacy of monoclonal antibodies against vaccinial B5 and L1 proteins. Antivir Res. 2017; 144: 8-20.

[9] Liu Q, Fan C, Zhou S, et al. Bioluminescent imaging of vaccinia virus infection in immunocompetent and immunodeficient rats as a model for human smallpox. Sci Rep. 2015; 5: 11397.

[10] Brandt CR, Larsen IV, Clausius H. Susceptibility of C57BL/6 and Balb/c mice to vaccinia virus keratitis. Invest Ophthalmol Vis Sci. 2014; 55(13): 6265.

[11] Hou F, Zhang Y, Liu X, et al. mRNA vaccines encoding fusion proteins of monkeypox virus antigens protect mice from vaccinia virus challenge. Nat Commun. 2023; 14(1): 5925.

[12] Isidro J, Borges V, Pinto M, et al. Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus. Nat Med. 2022; 28(8): 1569-1572.

[13] Happi C, Adetifa I, Mbala P, et al. Urgent need for a non-discriminatory and non-stigmatizing nomenclature for monkeypox virus. PLoS Biol. 2022; 20(8): e3001769.

[14] Likos AM, Sammons SA, Olson VA, et al. A tale of two clades: monkeypox viruses. J Gen Virol. 2005; 86(Pt 10): 2661-2672.

[15] Bunge EM, Hoet B, Chen L, et al. The changing epidemiology of human monkeypox-a potential threat? A systematic review. PLoS Negl Trop Dis. 2022; 16(2): e0010141.

[16] Warner BM, Klassen L, Sloan A, et al. In vitro and in vivo efficacy of tecovirimat against a recently emerged 2022 monkeypox virus isolate. Sci Transl Med. 2022; 14(673): eade7646.

[17] Earl PL, Americo JL, Moss B. Lethal monkeypox virus infection of CAST/EiJ mice is associated with a deficient gamma interferon response. J Virol. 2012; 86(17): 9105-9112.

[18] Earl PL, Americo JL, Moss B. Natural killer cells expanded in vivo or ex vivo with IL-15 overcomes the inherent susceptibility of CAST mice to lethal infection with orthopoxviruses. PLoS Pathog. 2020; 16(4): e1008505.

[19] Americo JL, Moss B, Earl PL. Identification of wild-derived inbred mouse strains highly susceptible to monkeypox virus infection for use as small animal models. J Virol. 2010; 84(16): 8172-8180.

[20] Americo JL, Earl PL, Moss B. Virulence differences of mpox (monkeypox) virus clades I, IIa, and IIb.1 in a small animal model. Proc Natl Acad Sci USA. 2023; 120(8): e2220415120.

[21] Earl PL, Americo JL, Moss B. Insufficient innate immunity contributes to the susceptibility of the castaneous mouse to orthopoxvirus infection. J Virol. 2017; 91(19): e01042-17.

[22] Chiuppesi F, Zaia JA, Gutierrez-Franco MA, et al. Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus. Commun Med. 2024; 4(1): 19.

[23] Phelps A, Gates AJ, Hillier M, Eastaugh L, Ulaeto DO. Comparative efficacy of replicating smallpox vaccine strains in a murine challenge model. Vaccine. 2005; 23(27): 3500-3507.

[24] Huang B, Zhao H, Song J, et al. Isolation and characterization of monkeypox virus from the first case of monkeypox—Chongqing municipality, China, 2022. China CDC Wkly. 2022; 4(46): 1019-1024.

[25] Fang M, Sigal LJ. Antibodies and CD8+ T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus. J Immunol. 2005; 175(10): 6829-6836.

[26] Wei Q, Huang B, Huang W, et al. The first strain of monkeypox isolated in the Chinese mainland and preserved at the National Pathogen Resource Center of China. Inf Med. 2022; 1(4): 288-291.

[27] Zhao H, Wang W, Zhao L, et al. The first imported case of monkeypox in the mainland of China—Chongqing municipality, China, September 16, 2022. China CDC Wkly. 2022; 4(38): 853-854.

[28] Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15(12): 550.

[29] Zuiani A, Dulberger CL, De Silva NS, et al. A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease. Cell. 2024; 187(6): 1363-1373.e1312.

[30] Hao J, Liu C, Gu Z, Yang X, Lan X, Guo X. Dysregulation of Wnt/β-catenin signaling contributes to intestinal inflammation through regulation of group 3 innate lymphoid cells. Nat Commun. 2024; 15(1): 2820.

[31] Li X, Zhang M, Huang X, et al. Ubiquitination of RIPK1 regulates its activation mediated by TNFR1 and TLRs signaling in distinct manners. Nat Commun. 2020; 11(1): 6364.

[32] Massagué J, Sheppard D. TGF-β signaling in health and disease. Cell. 2023; 186(19): 4007-4037.

[33] Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol. 2006; 24: 99-146.

[34] Aizawa T, Wei H, Miano JM, Abe J, Berk BC, Yan C. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells. Circ Res. 2003; 93(5): 406-413.

[35] Gong T, Si K, Liu H, Zhang X. Research advances in the role of MAPK cascade in regulation of cell growth, immunity, inflammation, and cancer. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022; 47(12): 1721-1728.

[36] Huber VC, Lynch JM, Bucher DJ, Le J, Metzger DW. Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections. J Immunol. 2001; 166(12): 7381-7388.

[37] Plas DR, Thompson CB. Akt-dependent transformation: there is more to growth than just surviving. Oncogene. 2005; 24(50): 7435-7442.

[38] Cass LA, Summers SA, Prendergast GV, Backer JM, Birnbaum MJ, Meinkoth JL. Protein kinase A-dependent and -independent signaling pathways contribute to cyclic AMP-stimulated proliferation. Mol Cell Biol. 1999; 19(9): 5882-5891.

[39] Summers SA, Garza LA, Zhou H, Birnbaum MJ. Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. Mol Cell Biol. 1998; 18(9): 5457-5464.

[40] Clapham DE. Calcium signaling. Cell. 1995; 80(2): 259-268.

[41] Cheng Y, Jiao L, Chen J, et al. Duck Tembusu virus infection activates the MKK3/6-p38 MAPK signaling pathway to promote virus replication. Vet Microbiol. 2024; 288: 109951.

RIGHTS & PERMISSIONS

2025 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.